The field of diabetes treatment continues to experience a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide stand out as potential game-changers. This https://alvinyimv570851.bloggerchest.com/39098278/novel-glp-1-receptor-agonists-retatrutide-and-trizepatide